Publications

Detailed Information

Comparison of Risk Factors for Bilateral and Unilateral Eye Involvement in Normal-Tension Glaucoma

DC Field Value Language
dc.contributor.authorKim, Cinoo-
dc.contributor.authorKim, Tae-Woo-
dc.date.accessioned2012-06-29T09:02:06Z-
dc.date.available2012-06-29T09:02:06Z-
dc.date.issued2009-03-
dc.identifier.citationINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE; Vol.50 3; 1215-1220ko_KR
dc.identifier.issn0146-0404-
dc.identifier.urihttps://hdl.handle.net/10371/78001-
dc.description.abstractPURPOSE. To compare the risk factors for bilateral and unilateral disease in normal-tension glaucoma (NTG). METHODS. The study analyzed data from consecutive NTG patients with either bilateral (n = 194) or unilateral ( n = 193) disease. Multivariate regression models were used to evaluate the following potential risk factors for bilateral eye involvement: age, sex, central corneal thickness, mean deviation in standard automated perimetry, mean and fluctuation of diurnal intraocular pressure (IOP) without glaucoma medication, spherical equivalent, family history of glaucoma, and underlying systemic disease such as diabetes mellitus, hypertension, hypercholesterolemia, ischemic heart disease, previous cerebrovascular accident, migraine, and cold extremities. RESULTS. Multivariate analysis showed that worse mean deviation in the first affected eye (odds ratio [OR], 1.19/1 dB decrease; P < 0.001), diabetes mellitus (OR, 2.31; P = 0.004), previous cerebrovascular accident (OR, 4.27; P = 0.039), and mean IOP greater than 14 mm Hg in the less affected eye (OR, 1.66; P = 0.030) were significantly associated with bilateral eye involvement in NTG. CONCLUSIONS. Besides being an indicator of disease severity (worse mean deviation), diabetes mellitus, previous cerebrovascular accident, and IOP were associated with bilateral eye involvement. These data suggest that systemic vascular factors and IOP play significant roles in the pathogenesis of NTG. It appears that although systemic vascular factors increase the susceptibility of the optic nerve, a certain level of pressure-induced stress is also required to cause glaucomatous optic neuropathy. (Invest Ophthalmol Vis Sci. 2009; 50: 1215-1220) DOI:10.1167/iovs.08-1886ko_KR
dc.language.isoenko_KR
dc.publisherASSOC RESEARCH VISION OPHTHALMOLOGY INCko_KR
dc.titleComparison of Risk Factors for Bilateral and Unilateral Eye Involvement in Normal-Tension Glaucomako_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김시누-
dc.contributor.AlternativeAuthor김태우-
dc.identifier.doi10.1167/iovs.08-1886-
dc.citation.journaltitleINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE-
dc.description.citedreferenceNgan R, 2007, AM J OPHTHALMOL, V144, P310-
dc.description.citedreferenceAinslie PN, 2007, EXP PHYSIOL, V92, P769, DOI 10.1113/expphysiol.2006.036814-
dc.description.citedreferenceMabuchi F, 2007, AM J OPHTHALMOL, V143, P125, DOI 10.1016/j.ajo.2006.09.028-
dc.description.citedreferenceKim S, 2006, MOL VIS, V12, P1016-
dc.description.citedreferenceSu WW, 2006, INVEST OPHTH VIS SCI, V47, P3390, DOI 10.1167/iovs.06-0024-
dc.description.citedreferenceGirkin CA, 2006, BRIT J OPHTHALMOL, V90, P679, DOI 10.1136/bjo.2005.086082-
dc.description.citedreferenceFu JH, 2006, J NEUROIMAGING, V16, P120, DOI 10.1111/j.1552-6569.2006.00030.x-
dc.description.citedreferenceSugiyama T, 2006, AM J OPHTHALMOL, V141, P394-
dc.description.citedreferenceSehi M, 2005, INVEST OPHTH VIS SCI, V46, P561, DOI 10.1167/iovs.04-1033-
dc.description.citedreferenceGRIESHABER MC, 2005, CURR OPIN OPHTHALMOL, V16, P79-
dc.description.citedreferenceBRENGTSSON B, 2005, GRAEFES ARCH CLIN EX, V243, P513-
dc.description.citedreferenceNouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017-
dc.description.citedreferenceBonovas S, 2004, DIABETIC MED, V21, P609-
dc.description.citedreferenceHosking SL, 2004, BRIT J OPHTHALMOL, V88, P406, DOI 10.1136/bjo.2002.008995-
dc.description.citedreferenceKanamori A, 2004, CURR EYE RES, V28, P47-
dc.description.citedreferenceHarris A, 2003, AM J OPHTHALMOL, V135, P144-
dc.description.citedreferenceLeske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48-
dc.description.citedreferenceFlammer J, 2002, PROG RETIN EYE RES, V21, P359-
dc.description.citedreferenceMaruyama I, 2002, TOHOKU J EXP MED, V197, P125-
dc.description.citedreferenceGordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714-
dc.description.citedreferenceKremmer S, 2001, CLIN EXP IMMUNOL, V125, P211-
dc.description.citedreferenceMarcus DM, 2001, J GLAUCOMA, V10, P177-
dc.description.citedreferenceLeske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89-
dc.description.citedreferenceIshida K, 2000, AM J OPHTHALMOL, V129, P707-
dc.description.citedreferenceAsrani S, 2000, J GLAUCOMA, V9, P134-
dc.description.citedreferenceZHANG I, 2000, CURR EYE RES, V20, P131-
dc.description.citedreferenceIshida K, 1998, J GLAUCOMA, V7, P372-
dc.description.citedreferenceSchulzer M, 1998, AM J OPHTHALMOL, V126, P487-
dc.description.citedreferenceBroadway DC, 1998, BRIT J OPHTHALMOL, V82, P862-
dc.description.citedreferencePoinoosawmy D, 1998, OPHTHALMOLOGY, V105, P988-
dc.description.citedreferenceMitchell P, 1997, OPHTHALMOLOGY, V104, P712-
dc.description.citedreferenceChihara E, 1997, OPHTHALMOLOGICA, V211, P66-
dc.description.citedreferenceDielemans I, 1996, OPHTHALMOLOGY, V103, P1271-
dc.description.citedreferencePALLAS F, 1996, PERFUSION, V11, P363-
dc.description.citedreferenceJONAS JB, 1994, AM J OPHTHALMOL, V118, P1-
dc.description.citedreferenceHAYREH SS, 1994, AM J OPHTHALMOL, V117, P603-
dc.description.citedreferenceTIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69-
dc.description.citedreferenceORGUL S, 1994, EUR J OPHTHALMOL, V4, P199-
dc.description.citedreferenceKLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499-
dc.description.citedreferenceSOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090-
dc.description.citedreferenceTIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369-
dc.description.citedreferenceCAPRIOLI J, 1991, AM J OPHTHALMOL, V111, P235-
dc.description.citedreferenceSHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133-
dc.description.citedreferenceCRICHTON A, 1989, OPHTHALMOLOGY, V96, P1312-
dc.description.citedreferenceDRANCE SM, 1988, AM J OPHTHALMOL, V105, P35-
dc.description.citedreferencePHELPS CD, 1985, INVEST OPHTH VIS SCI, V26, P1105-
dc.description.citedreferenceQUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135-
dc.description.citedreferencePERKINS ES, 1982, ARCH OPHTHALMOL-CHIC, V100, P1464-
dc.description.citedreferenceDANDONA P, 1978, BRIT MED J, V2, P325-
dc.description.citedreferenceBENTSON W, 1975, STROKE, V6, P497-
dc.description.citedreferenceHARRINGTON DO, 1959, AM J OPHTHALMOL, V47, P177-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share